Additional dexamethasone in chemotherapies with carboplatin and paclitaxel could reduce the impaired glycometabolism in rat models

Table 1 The pathology scores of pancreases in each group on day 4 after treatment

Groups	Edema (Mean ± SD)	Necrosis (Mean ± SD)	Inflammation (Mean ± SD)	Hemorrhage (Mean ± SD)	Total (Mean ± SD)
Group1	0.00 ± 0.00	0.50 ± 0.58	0.00 ± 0.00	0.25 ± 0.50	0.75 ± 0.50
Group1’	0.50 ± 0.41	0.00 ± 0.00	0.50 ± 0.58	0.00 ± 0.00	1.00 ± 0.91
Group2	0.38 ± 0.25	0.00 ± 0.00	0.50 ± 0.58	0.50 ± 0.58	1.38 ± 1.03
Group2’	0.25 ± 0.29	0.25 ± 0.50	0.25 ± 0.50	0.50 ± 0.58	1.25 ± 1.19
Group3	0.63 ± 0.63 ^*	0.00 ± 0.00	1.00 ± 0.82 ^*	0.25 ± 0.50	1.88 ± 1.80
Group3’	0.63 ± 0.48 ^*	0.25 ± 0.50	1.25 ± 0.96 ^*	0.25 ± 0.50	2.38 ± 1.25 ^*
Group4	0.88 ± 0.25 ^*	0.00 ± 0.00	0.75 ± 0.50	0.25 ± 0.50	1.88 ± 0.85
Group4’	0.88 ± 0.25 ^*	0.50 ± 0.58	1.75 ± 0.50 ^*	0.00 ± 0.00	3.13 ± 0.63 ^*

ISSN: 1471-2407